Skip to main content

Advertisement

Log in

Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Periprocedural myocardial injury is a prognostically important complication of percutaneous coronary intervention (PCI). However, it still remains unclear whether and how intensive atorvastatin therapy attenuates the unfavorable inflammatory responses of monocytes associated with PCI. The aim of the study was to investigate the impact of intensive atorvastatin therapy on inflammatory responses of monocytes in Chinese patients with unstable angina who received PCI in order to explore the potential anti-inflammatory mechanism. Ninety-six patients with unstable angina were randomly assigned to atorvastatin 80 mg (intensive) or atorvastatin 20 mg (conventional) treatment at a 1:1 ratio. Creatine kinase MB (CK-MB), cTnI, hs-CRP, and IL-6 were assessed, and circulating CD14+ monocytes were simultaneously obtained using CD14 MicroBeads 2 h before and 24 h after PCI. Plasma levels of CK-MB, cTnI, hs-CRP, and IL-6 were higher in the conventional dose group versus those in the intensive dose group following PCI. Furthermore, intensive atorvastatin treatment markedly reduced the expressions and responses of Toll-like receptor 2 (TLR2), TLR4, and CCR2 of CD14+ monocytes versus the conventional dose group and significantly increased the activated peroxisome-proliferator-activated receptor (PPAR) γ in the CD14+ monocytes post-PCI. Notably, the changes in responses of TLR2, TLR4, and CCR2 of CD14+ monocytes between the two groups were all reversed by PPARγ antagonist and augmented by PPARγ agonist. In conclusion, a single high (80 mg) loading dose of atorvastatin reduced the inflammatory response in Chinese patients with unstable angina following PCI. The anti-inflammatory role of intensive atorvastatin was possibly due to attenuation of inflammatory response in monocytes via PPARγ activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nusca, A., R. Melfi, G. Patti, and G.D. Sciascio. 2010. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications. Future Cardiology 6: 579–89.

    Article  CAS  PubMed  Google Scholar 

  2. Briel, M., N. Vale, G.G. Schwartz, J.A. de Lemos, F. Colivicchi, F.R. den Hartog, et al. 2012. Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients. International Journal of Cardiology 158: 93–100.

    Article  PubMed  Google Scholar 

  3. Pasceri, V., G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio, et al. 2004. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110: 674–8.

    Article  CAS  PubMed  Google Scholar 

  4. Patti, G., M. Chello, V. Pasceri, D. Colonna, A. Nusca, M. Miglionico, et al. 2006. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Journal of the American College of Cardiology 48: 1560–6.

    Article  CAS  PubMed  Google Scholar 

  5. Patti, G., V. Pasceri, G. Colonna, M. Miglionico, D. Fischetti, G. Sardella, et al. 2007. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology 49: 1272–8.

    Article  CAS  PubMed  Google Scholar 

  6. Norris, D.M., and J.R. Anderson. 2012. Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction. Cardiology in Review 20: 319–24.

    Article  PubMed  Google Scholar 

  7. Briguori, C., G. Visconti, A. Focaccio, B. Golia, A. Chieffo, A. Castelli, et al. 2009. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. Journal of the American College of Cardiology 54: 2157–63.

    Article  CAS  PubMed  Google Scholar 

  8. Toutouzas, K., A. Colombo, and C. Stefanadis. 2004. Inflammation and restenosis after percutaneous coronary interventions. European Heart Journal 25: 1679–87.

    Article  CAS  PubMed  Google Scholar 

  9. Liuzzo, G., A. Buffon, L.M. Biasucci, J.R. Gallimore, G. Caligiuri, A. Vitelli, et al. 1998. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 98: 2370–6.

    Article  CAS  PubMed  Google Scholar 

  10. Liuzzo, G., M. Santamaria, L.M. Biasucci, M. Narducci, V. Colafrancesco, A. Porto, et al. 2007. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. Journal of the American College of Cardiology 49: 185–94.

    Article  CAS  PubMed  Google Scholar 

  11. Norata, G.D., K. Garlaschelli, M. Ongari, S. Raselli, L. Grigore, F. Benvenuto, et al. 2005. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. Journal of Internal Medicine 258: 21–7.

    Article  CAS  PubMed  Google Scholar 

  12. Candore, G., A. Aquino, C.R. Balistreri, M. Bulati, D. Di Carlo, M.P. Grimaldi, et al. 2006. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Annals of the New York Academy of Sciences 1067: 282–7.

    Article  CAS  PubMed  Google Scholar 

  13. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nature Reviews Immunology 4: 499–511.

    Article  CAS  PubMed  Google Scholar 

  14. Sakai, N., T. Wada, K. Furuichi, K. Shimizu, S. Kokubo, A. Hara, et al. 2006. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. Journal of Leukocyte Biology 79: 555–63.

    Article  CAS  PubMed  Google Scholar 

  15. Schober, A., A. Zernecke, E.A. Liehn, P. von Hundelshausen, S. Knarren, W.A. Kuziel, et al. 2004. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circulation Research 95: 1125–33.

    Article  CAS  PubMed  Google Scholar 

  16. Das, S.K., and R. Chakrabarti. 2006. Role of PPAR in cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery 1: 193–209.

    Article  CAS  PubMed  Google Scholar 

  17. Francis, G.A., J.S. Annicotte, and J. Auwerx. 2003. PPAR agonists in the treatment of atherosclerosis. Current Opinion in Pharmacology 3: 186–91.

    Article  CAS  PubMed  Google Scholar 

  18. Grip, O., S. Janciauskiene, and S. Lindgren. 2002. Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes. Inflammation Research: Official Journal of the European Histamine Research Society [et al] 51: 58–62.

    Article  CAS  Google Scholar 

  19. Yano, M., T. Matsumura, T. Senokuchi, N. Ishii, Y. Murata, K. Taketa, et al. 2007. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circulation Research 100: 1442–51.

    Article  CAS  PubMed  Google Scholar 

  20. Sanchez-Margalet, V., J.M. Cubero, C. Martin-Romero, J. Cubero, J.M. Cruz-Fernandez, and R. Goberna. 2002. Inflammatory response to coronary stent implantation in patients with unstable angina. Clinical Chemistry and Laboratory Medicine: CCLM / FESCC 40: 769–74.

    Article  CAS  Google Scholar 

  21. Novack, V., M. Pencina, D.J. Cohen, N.S. Kleiman, C.H. Yen, J.F. Saucedo, et al. 2012. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Archives of Internal Medicine 172: 502–8.

    Article  PubMed  Google Scholar 

  22. Arefieva, T.I., T.L. Krasnikova, A.V. Potekhina, N.U. Ruleva, P.I. Nikitin, T.I. Ksenevich, et al. 2011. Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting. Inflammation Research: Official Journal of the European Histamine Research Society [et al] 60: 955–64.

    Article  CAS  Google Scholar 

  23. Dewald, O., P. Zymek, K. Winkelmann, A. Koerting, G. Ren, T. Abou-Khamis, et al. 2005. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circulation Research 96: 881–9.

    Article  CAS  PubMed  Google Scholar 

  24. Frangogiannis, N.G., O. Dewald, Y. Xia, G. Ren, S. Haudek, T. Leucker, et al. 2007. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115: 584–92.

    Article  CAS  PubMed  Google Scholar 

  25. Ziegler-Heitbrock, L., P. Ancuta, S. Crowe, M. Dalod, V. Grau, D.N. Hart, et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Tangshan Science & Technology program (13130254a).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Cheng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, J., Liu, C., Zhang, L. et al. Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation. Inflammation 38, 1415–1423 (2015). https://doi.org/10.1007/s10753-015-0116-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-015-0116-2

KEY WORDS

Navigation